Explore the latest technologies, newest medical and drug discoveries, financing, IP issues and more.

  • Algae -- San Diego's claim to biofuel fame

    When scientists, entrepreneurs and others involved in the biofuels industry converged in San Diego during the second week of October for the third annual Algae Biomass Summit, they struck a decidedly different note compared with the first two years of the summit.

  • Aerotek supports staffing for biotech industry in San Diego

    Aerotek Inc., a leading U.S. staffing provider, is a direct source to provide valuable staffing services within the San Diego business community. As a key staffing partner throughout the San Diego community for more than 14 years, Aerotek's experienced staffing professionals locate, screen and place candidates in positions for a variety of industries, including the biotech industry.

  • EU approves Merck takeover of Schering-Plough

    BRUSSELS -- The European Union approved Merck & Co.'s (NYSE: MRK) proposed takeover of Schering-Plough (NYSE: SGP), which would create the second-biggest global producer of prescription medicines.

  • GE launches $250 million health care tech fund

    NEW YORK -- GE Healthcare said Wednesday it plans to expand a cancer drug research partnership with Eli Lilly & Co. (NYSE: LLY), making a two-year-old partnership official in the process.

  • Eli Lilly CEO banking on new drug pipeline

    INDIANAPOLIS -- There are some life experiences few will ever have. And as the oldest of nine children and CEO of a Fortune 500 company, John Lechleiter has a couple under his belt.

  • Life science market reflects opportunity

    The San Diego laboratory market consists of approximately 14 million square feet, with countywide vacancy at 10.3 percent, remaining flat since the end of second-quarter 2009.

  • Local emergency response teams prepared for bioterrorism attack

    When it comes to an emergency response to a bioterrorism attack, San Diego is doing its part to be prepared.

  • San Diego company takes unique approach to agricultural technology

    The future of food production may not have to involve genetically altered crops or chemically enhanced plants, thanks to an enterprising San Diego company.

  • Two UCSD malaria projects get Gates Foundation funding

    The Bill & Melinda Gates Foundation included two local research projects in its recent round of funding for its Grand Challenges Explorations program.

  • Lpath receives grants

    Lpath (OTC: LPTN), which specializes in lipid-based therapeutics, has been awarded two Phase 1 grants totaling $300,000 from the National Cancer Institute's Small Business Innovation Research (SBIR) Program.

  • Ardea sees positive results in gout drug study

    On Monday, Ardea Biosciences Inc. (Nasdaq: RDEA) announced additional positive results from an ongoing study of its treatment for hyperuricemia and gout.

  • Venture capital slump misses San Diego

    San Diego bucked the national venture capital trend in the third quarter, posting a 20-percent increase in dollars attracted while the U.S. average stalled, according to a report from industry tracker Dow Jones VentureSource.

  • Quidel launches new research kit

    Quidel Corp. (Nasdaq: QDEL), a San Diego-based provider of rapid point-of-care diagnostic tests, has launched its MicroVue C5a EIA Kit for research use only.

  • Acadia to halve work force

    Acadia Pharmaceuticals (Nasdaq: ACAD) plans to cut its work force in half after disappointing results from its Phase 3 trial with Parkinson's psychosis treatment pimavanserin.

  • Stemedica moving forward with trials for stroke treatment

    Stemedica Cell Technologies Inc. announced Thursday that it has completed meetings with the FDA and plans to go ahead with studies on a new stroke treatment.

  • Cardium announces $6M offering

    Cardium Therapeutics (NYSE Amex: CXM) has announced a registered direct offering of common stock to selected investors for aggregate gross proceeds of $6.0 million.

  • La Jolla Pharmaceutical to seek dissolution approval

    La Jolla Pharmaceutical Co. (Nasdaq: LJPC) has set a date for its stockholders to vote on whether to liquidate the practically defunct biotech.

  • Patent office scraps new rules

    Local intellectual property attorneys are applauding last week's decision by the U.S. Patent & Trademark Office to rescind its proposed rules changes.

  • Biomimics say San Diego could be hub on new industry

    From airplane wings to fan blades to the eye black athletes wear to deflect the sun, mankind has been modeling its products after the natural world since it started making products in the first place.

  • Navy to fund Vical's swine flu vaccine development

    The U.S. Navy has awarded Vical Inc. (Nasdaq: VICL) a contract for $1.25 million to support a Phase 1 clinical trial of the company's vaccine for H1N1 influenza, more commonly known as swine flu.

Inside Biotech

Profiles

National News

  • EU approves Merck takeover of Schering-Plough

    BRUSSELS -- The European Union approved Merck & Co.'s (NYSE: MRK) proposed takeover of Schering-Plough (NYSE: SGP), which would create the second-biggest global producer of prescription medicines.

  • GE launches $250 million health care tech fund

    NEW YORK -- GE Healthcare said Wednesday it plans to expand a cancer drug research partnership with Eli Lilly & Co. (NYSE: LLY), making a two-year-old partnership official in the process.

  • Eli Lilly CEO banking on new drug pipeline

    INDIANAPOLIS -- There are some life experiences few will ever have. And as the oldest of nine children and CEO of a Fortune 500 company, John Lechleiter has a couple under his belt.

Archived Reports

Inside Biotech - 2014

Learn about innovations and trends in San Diego’s thriving biotech and life science industries.

Inside Biotech - 2011

Take an in-depth look at San Diego's vibrant life sciences sector with our annual publication, Inside Biotech.

Inside Biotech - 2008

Find out more about San Diego life science companies as we explore the latest technologies, drug discoveries, financing, IP updates and more.

Inside Biotech - 2007

The Daily Transcript takes an in-depth look at the biotech sector, including financing, educational needs and the latest research coming out of local companies.

Inside Biotech - 2006

This special report takes an in-depth look at the biotech sector of our local economy. We'll discuss what's going on in the biotech arena from many angles and explore the latest technologies used in drug discovery. We'll also review the latest intellectual property news.

Inside Biotech - 2005

The Women's Business Center of California Business to Business Expo is all about women-owned businesses showcasing their products and services to other women and the business community at large. The event will be held Thursday, Oct. 20, from 9:30 a.m. to 1 p.m. at National University, 9388 Lightwave Ave.